Multi-Millionaires!, shatter all rock and
metal!!!! Like shards away all when they make their
presence known!! they always come in Peace and leave in
Peace!!! The Destruction left! Becomes mercenary plot!!!
and Defensive Hold for the onslaught! So now, the
silent and quiet of the Dawn awaits all!! Us, DTS' and
SMTS" lined up in defensive positions for the Real MM's
to hit and frag the beyond Hills and then git the h
out and We do the rest!!! Or are they chickens under
the skirts of Radcliffe hehehe I as a Chippewa Chief
Grandson think they are! Hiding under skirts
hehehehahahaHohohohoho now I know what blueskin means hohohoho!!!!! Til
the Eagle Flys in Blue Hahahahaha!
We have come! We've Seen, and We've Conquered!!!!
There is no Way ONXX is going to be a factor in
Warner-Lambert takeover at This Critical Stage!!! Mind All!!, 11
million shares to the public!! And none to Warner-Lambert
no matter what their cost! They took a little but,
we the shareholders take the price! and that price
is astronumerical!! to say the least after today!!
Listen, all shareholders we have U>S> & Europe!
Patents!!! Hold for Gold!! and to hell freezes over OUR
SHARES! Not so close so close! til ASCO May 16! Hold for
Gold!!!! We prop up and hold up ONXX and can accelerate it
up in a 1/2 hr!!! We are thee StockHolders!!!!
> needs to be tested for efficacy
safety on a larger scale
In other words, it could
turn out that it isn't
effective or safe enough.
History is full of
"promising" drugs that didn't
survive Phase III.
Of course, most of the people
posting here have
already invested in ONXX I expect,
speculating that the optimistic view
Money/support to conduct a phase III trial is a
dire necessity for ONXX, and it has to come from
somewhere. I am not sure how you mean Onyx-015 will bypass
later phases, it still needs to be tested for efficacy
and safety on a larger scale. Support from a large
pharmaceutical company, in regards to late phase Onyx-015
development, may serve to inform a wider audience of the
potential of the drug. Theoretically, a large public demand
may influence the FDA to view Onyx-015 as a high
priority drug candidate, which may speed things up a bit.
I would not be so bold as to call Onyx-015 the cure
for cancer, every "magic bullet" seems to have some
drawbacks, and this is no exception. However, I do share
I heard that onyx-015 may
(by)pass other phrases quickly and
make cancer cure
available to hospitals. there are millions of
cancer patient is waiting for onyx-015, they can
FDA for delaying the cure and cause thier death.
I noticed an interesting Reuters article with the
head of WLA, who mentioned that the company is in a
strong financial position, and does not want to "leave
the money in the bank"...they have recently acquired
Agouron Pharm., and the article suggested they will be
i wonder if this will in any way
affect ONXX, not necessarily a takeover, but perhaps
more extensive collaboration....as far as I understand
the WLA collaboration does not involve ONYX-015, but
you must admit that results are promising, and the
patents (new and old) must be enticing.
article is from 4/27 and is posted on the WLA News board
(very short, very little detail)
Onyx has been ready to move since mid-year 1996.
I personally think at some point in time it will.
In fact, the potential is so large, that I would
recommend holding a little piece of it in any and all stock
portfolios. One of two courses of action are going to take
place with Onyx. I don't know which. One, Onyx would be
bought out by a larger drug company. And two, Onyx-015
goes into Phase III trails. The problem is, Onyx
doesn't know HOW Onyx-015 works. Money is not an issue
because Onyx can come to the stockholders and offer 1
share of stock for every two that are owned at a
reduced price. Any stockholder would be able to pick up
any of these unclaimed options at that price. Any
individual stockholder would not get everything extra they
asked for because of an over subscription. If the
option price were $5.00, this would add $25,000,000 to
Onyx's balance sheet.